GO
Loading...

Enter multiple symbols separated by commas

Ranbaxy Makes bid for Merck's Generic Drugs Unit

Indian drugmaker Ranbaxy Laboratories said Tuesday it has submitted a bid for the generics unit of Germany's Merck but did not disclose how much it was offering.

Analysts believe the unit could be worth as much as 5 billion euros ($6.58 billion). Last year, the unit's sales rose 6.9% to 1.8 billion euros ($2.37 billion).

Ranbaxy told The Associated Press in an e-mail that the bid had been submitted to the German drug and chemical maker. Chief Executive Dr. Malvinder Singh said his company would not get caught up in a bidding war for the unit.

"We are looking to evaluate the asset and we are going to be very practical about it," he said in a statement sent to The AP. "We are not in a rat race for acquisitions but are focused on creating value for our shareholders in the best way we can."

A Merck spokeswoman had no comment about the bid.

Merck said last month it had started contacting companies that may be interested in acquiring its generics drugs unit, reiterating a previous statement that it was amenable to the possible sale of the division.

So far, two companies have publicly expressed their interest, Ranbaxy and Iceland's Actavis Group HF.

Darmstadt, Germany-based Merck is the world's oldest pharmaceuticals company. It has been entirely separate from New Jersey-based Merck & Co. since the end of World War I and employs some 29,000 people.

Shares of Merck fell more than half a percent to 93.62 euros ($123.17) in Frankfurt.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video

  • Cramer: Here's a sign the market could rally

    Wall Street's been soaking in red, but "Mad Money" host Jim Cramer has one signal to watch for that could point to another run.

  • Burger war maneuvers

    Cramer looks at the number of company's selling burgers and tries to determine the quality names, as well as those to avoid.

  • Cramer: What's driving defense?

    Cramer says that even though President Obama has made it clear the US can no longer be the world's policeman, the country can become the world's arms dealer. Profiting from defense spending.